Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Galani

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|January 27, 2024
Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque CharacteristicsSotirios Kotsovilis, Maria Salagianni, Aimilia Varela, et al.
Cancer Research|March 5, 2009
Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphomaMichael K Kiessling, Claus D Klemke, Marcin M Kaminski, et al.
Journal of Chemotherapy (Florence, Italy)|April 15, 2005
Carboplatin hypersensitivity reactions: a single institution experienceM P Zorzou, E Efstathiou, E Galani, et al.
International Journal of Cancer|December 23, 2009
Regulatory T cells control macrophage accumulation and activation in lymphomaIoanna E Galani, Marco Wendel, Ana Stojanovic, et al.
Anticancer Research|April 13, 2001
Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patientsG Agiostratidou, I Sgouros, E Galani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Treatment of Waldenstrom's macroglobulinemia with thalidomideM A Dimopoulos, A Zomas, N A Viniou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patientsG M Marx, G M Blake, E Galani, et al.
Oncology|February 13, 2009
Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates aloneC Christodoulou, A Pervena, G Klouvas, et al.
Immunity|May 18, 2017
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host FitnessIoanna E Galani, Vasiliki Triantafyllia, Evridiki-Evangelia Eleminiadou, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|January 27, 2024
Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque CharacteristicsSotirios Kotsovilis, Maria Salagianni, Aimilia Varela, et al.
Cancer Research|March 5, 2009
Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphomaMichael K Kiessling, Claus D Klemke, Marcin M Kaminski, et al.
Journal of Chemotherapy (Florence, Italy)|April 15, 2005
Carboplatin hypersensitivity reactions: a single institution experienceM P Zorzou, E Efstathiou, E Galani, et al.
International Journal of Cancer|December 23, 2009
Regulatory T cells control macrophage accumulation and activation in lymphomaIoanna E Galani, Marco Wendel, Ana Stojanovic, et al.
Anticancer Research|April 13, 2001
Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patientsG Agiostratidou, I Sgouros, E Galani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Treatment of Waldenstrom's macroglobulinemia with thalidomideM A Dimopoulos, A Zomas, N A Viniou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patientsG M Marx, G M Blake, E Galani, et al.
Oncology|February 13, 2009
Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates aloneC Christodoulou, A Pervena, G Klouvas, et al.
Immunity|May 18, 2017
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host FitnessIoanna E Galani, Vasiliki Triantafyllia, Evridiki-Evangelia Eleminiadou, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
Pageof 4